Essen评分预测无冠脉疾病史TIA或缺血性卒中后的心肌梗死
基于牛津血管研究2002至2014年2555例TIA或卒中患者,无既往冠心病者10年心肌梗死风险随Essen评分从≤1分的0.9%升至≥5分的29.8%;评分≥4分者心肌梗死与复发性卒中风险同既往冠心病患者相当。
要点
- Essen评分可对无冠心病史TIA/卒中患者进行心肌梗死风险分层。
- 评分≥4分者10年心肌梗死风险与既往冠心病患者相近。
- Essen评分对复发性缺血性卒中的预测价值弱于对心肌梗死的预测。
核心结论
- Essen评分可简单风险分层无既往冠心病的TIA/卒中患者,识别心肌梗死和复发性卒中高风险亚组。
主要发现
- 无既往冠心病患者(n=2017,78.9%)10年心肌梗死风险从Essen评分≤1分的0.9%(95%CI 0-1.9)到≥5分的29.8%(95%CI 7.7-46.6),C统计量=0.64(95%CI 0.57-0.71;P<0.001)。
- Essen评分对复发性缺血性卒中风险的预测趋势较弱(C统计量=0.57,95%CI 0.54-0.60;差异P=0.0460)。
- 无冠心病者Essen评分≥4分(n=294,11.5%)与既往冠心病者(n=538,21.1%)10年心肌梗死风险相似(17.2%[95%CI 6.9-26.3] vs 16.9%[95%CI 11.5-22.0]),复发性卒中风险亦相似(40.4%[95%CI 26.7-51.6] vs 32.4%[95%CI 25.2-38.8])。
临床怎么用
- 对无冠心病史的TIA/卒中患者可用Essen评分识别心肌梗死和复发卒中高危者,以考虑更强化治疗或纳入临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- More intensive secondary prevention with newer drugs may be cost-effective in patients with coronary artery disease (CAD). Whether some subgroups of patients who had a transient ischemic attack (TIA) or ischemic stroke, but no prior CAD are at similar high risk of myocardial infarction as those with prior CAD remains unclear. We determined whether the Essen score identified a subset of TIA/stroke patients without known prior CAD who, nevertheless, had a high risk of myocardial infarction on current secondary prevention management. Methods- In a population-based cohort (Oxford Vascular Study) of consecutive TIA or ischemic stroke patients recruited from 2002 to 2014, 10-year actuarial risks of myocardial infarction and of recurrent ischemic stroke were determined by face-to-face follow-up in patients with and without prior CAD using Kaplan-Meier analyses. Predictive value of the Essen score was assessed with C statistic. Results- Of 2555 patients with TIA/stroke (13 070 patient-years of follow-up), 10-year risk of myocardial infarction in those without prior CAD (n=2017, 78.9%) ranged from 0.9% (95% CI, 0-1.9) at Essen score ≤1 to 29.8% (95% CI, 7.7-46.6) in those with a score ≥5 (C statistic =0.64 [95% CI, 0.57-0.71]; P<0.001). The score tended to be less predictive (difference: P=0.0460) for the risk of recurrent ischemic stroke (C statistic =0.57 [95% CI, 0.54-0.60]). Compared with patients with prior CAD (n=538, 21.1%), an Essen risk score of ≥4 (n=294, 11.5%) in those without prior CAD identified a subgroup at similar high 10-year risks of myocardial infarction (17.2% [95% CI, 6.9-26.3] versus 16.9% [95% CI, 11.5-22.0]) and of recurrent stroke (40.4% [95% CI, 26.7-51.6] versus 32.4% [95% CI, 25.2-38.8]). Conclusions- The Essen score is a simple clinical score to risk-stratify patients with TIA/stroke without prior CAD and to identify subsets who may be at sufficiently high risk of myocardial infarction and recurrent stroke to justify more intensive treatment or inclusion in trials.
引用
- Boulanger M, Li L, Lyons S, et al. Essen Risk Score in Prediction of Myocardial Infarction After Transient Ischemic Attack or Ischemic Stroke Without Prior Coronary Artery Disease. Stroke. 2019. PMID: 31637970. doi:10.1161/STROKEAHA.119.025831
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。